Haemorrhagic brain metastasis from a thymic carcinoma

被引:14
作者
Al-Barbarawi, M
Smith, SF
Sekhon, LHS
机构
[1] Royal N Shore Hosp, Dept Neurosurg, St Leonards, NSW 2065, Australia
[2] Univ Sydney, St Leonards, NSW 2065, Australia
关键词
brain metastasis; frameless stereotactic craniotomy; radiotherapy; thymic carcinoma; thymic epithelial tumours; TET;
D O I
10.1016/j.jocn.2003.05.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Brain metastasis from thymic carcinoma is extremely rare, and there is still no consensus regarding the best management of thymic metastasis to the central nervous system. Here, we report the first-known Australian case. A review of the current literature and the characteristics of thymic tumours with brain metastasis indicate that aggressive management may be able to improve long-term outcomes for these patients. A 49-year-old man presented 2 weeks after thoracotomy for thymic carcinoma resection with a 2-day history of headache, right-sided weakness and expressive dysphasia. CT and MR scans revealed two metastatic brain lesions, one within the left frontal lobe with cystic necrosis and haemorrhage, the other deep in the parietal lobe adjacent to the left ventricle with a lesser degree of haemorrhage. The patient underwent frameless stereotactic craniotomy for excision of the frontal lesion. Histopathology confirmed poorly differentiated thymic carcinoma. Post-operatively his weakness and speech improved dramatically, and he was discharged home within a week, with radiotherapy and chemotherapy to follow. However, he represented with rapidly worsening symptoms and died within a week. Thymic carcinoma is a rare tumour, displaying malignant features clinically and histopathologically with local invasion to adjacent organs. Metastasis is predominantly to lung, bone, liver and kidney, with less predilection for the central nervous system. Treatment for thymic carcinoma is multimodal, but outcome remains poor and life expectancy is very short when brain metastasis with haemorrhage is present. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:190 / 194
页数:5
相关论文
共 27 条
[1]  
Ahn JY, 2002, J NEURO-ONCOL, V58, P193
[2]   Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis - A retrospective study of 90 tumors [J].
Chalabreysse, L ;
Roy, P ;
Cordier, JF ;
Loire, R ;
Gamondes, JP ;
Thivolet-Bejui, F .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (12) :1605-1611
[3]   OBSERVER VARIATION IN THE HISTOPATHOLOGICAL CLASSIFICATION OF THYMOMA - CORRELATION WITH PROGNOSIS [J].
DAWSON, A ;
IBRAHIM, NBN ;
GIBBS, AR .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (06) :519-523
[4]   BRAIN METASTASIS OF AN INVASIVE THYMOMA [J].
DEWES, W ;
CHANDLER, WF ;
GORMANNS, R ;
EBHARDT, G .
NEUROSURGERY, 1987, 20 (03) :484-486
[5]  
FLETCHER CD, 2000, DIAGNOSTIC HISTOPATH, P1270
[6]   Multimodal treatment of metastatic thymic carcinoma including high-dose chemotherapy with autologous stem cell transplantation - Report of a case with more than 4-year disease-free survival [J].
Geffen, DB ;
Benharroch, D ;
Yellin, A ;
Ariad, S ;
Or, R ;
Cohen, Y .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (06) :566-569
[7]   High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience [J].
Hanna, N ;
Gharpure, VS ;
Abonour, R ;
Cornetta, K ;
Loehrer, PJ .
BONE MARROW TRANSPLANTATION, 2001, 28 (05) :435-438
[8]  
KOGA K, 1994, PATHOL INT, V44, P359
[9]  
LEGOLVAN DP, 1977, CANCER, V39, P2142, DOI 10.1002/1097-0142(197705)39:5<2142::AID-CNCR2820390531>3.0.CO
[10]  
2-Q